Shares of Personalis Inc. (PSNL), which soared more than 47% yesterday, following agreements with long-time collaborators Merck (MRK) and Moderna Inc. (MRNA), are up another 2% today in premarket trading.
Merck has agreed to purchase $50 million of Personalis' common stock in a private placement for $3.56 per share, which was the last reported closing price of Personalis' common stock as reported on the Nasdaq Global Market on December 18, 2024.
Subscribe to continue reading the article.
This article is part of our premium content offering.Subscribe with a RTTNews subscription.
Subscribe NowAlready subscribed? Sign in
For comments and feedback: editorial@rttnews.com